112 followers
YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance https://t.co/2Ws1jETqNi
YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance https://t.co/2Ws1jETqNi
New article: YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance https://t.co/64wfc0WTEO #melanoma #oncology https://t.co/ACZeaZrNlx
New research: YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance: Malignant melanoma, with its increasing incidence and high potential to form metastases, is one of the most aggressive types of skin malignancies… https://t.co/79hMj